Is DeepSeek a game-changer or just hype? A look at how China's AI surge challenges US tech dominance and what it means for ...

After the DeepSeek-induced ruction on Tuesday, Big Tech earnings reminded investors that it might be better to focus on companies already bringing in billions.

OpenAI — the company behind ChatGPT and a big part of Stargate — is partnering with the U.S. National Laboratories. NPR's ...

The seemingly overnight success of Chinese AI firm DeepSeek has catapulted its founder, Liang Wenfeng, to billionaire status. Here’s how.

NPR's Mary Louise Kelly talks with Chris Lehane, chief global affairs officer of OpenAI, about Stargate, DeepSeek and the future of AI development.

OpenAI has been cozying up to the government for a few years now, and it’s been turbocharged under the Trump Presidency.

Just days after announcing a version of ChatGPT designed for US government use, OpenAI is further entangling itself with the ...

DeepSeek’s disruption signals that the U.S. needs more competition, not Big Tech dominance, to be the world's AI leader ...

OpenAI has recently launched the ChatGPT Gov, the company's tailored version of ChatGPT, for the US government.

Top White House advisers this week expressed alarm that China’s DeepSeek may have benefited from a method that allegedly ...

The president joined leaders from OpenAI, Oracle and SoftBank to launch the ambitious project, but questions remain about its ...

Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.